Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 75
Healthy Volunteers: t
View:

• Migraine patients according to ICHD-3 criteria

• Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.

Locations
Other Locations
Spain
Vall d'Hebron University Hospital
RECRUITING
Barcelona
Contact Information
Primary
Patricia Pozo-Rosich, MD, PhD
ppozo@vhebron.net
(+34)934893000
Time Frame
Start Date: 2022-11-29
Estimated Completion Date: 2025-05
Participants
Target number of participants: 440
Treatments
Migraine Patients
Patients, male and female, with Episodic migraine, all ages.
Control group
Male and female without migraine or headache
Sponsors
Leads: Hospital Universitari Vall d'Hebron Research Institute

This content was sourced from clinicaltrials.gov